Sprycel 20mg tablet online | Apple pharmaceuticals
SPRYCEL 20MG
Description:
Sprycel 20mg is also contains second-generation inhibitor of the oncogenic tyrosine kinase BCR-ABL with 325-fold more potency than imatinib and is also able to inhibit imatinib-resistant BCR-ABL mutants. Sprycel 20mg is a prescription drug which used under the supervision of doctor.Indication:
Sprycel 20mg is indicated for the treatment of adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.Mechanism Of Action:
Sprycel 20mg is also contains second-generation inhibitor of the oncogenic tyrosine kinase BCR-ABL with 325-fold more potency than imatinib and is also able to inhibit imatinib-resistant BCR-ABL mutants.Sprycel 20mg is a prescription drug which used under the supervision of doctor.
Dosage and administration:
Sprycel indicated for Chronic Myeloid Leukaemia:
Newly diagnosed: Used for recently diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase initiate 100 mg PO qDay (morning or evening).Advanced CML:
Used for treatment of chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with support or intolerance to before therapy contains imatinib.
Precautions:
Sprycel will occur Hypokalaemia, hypomagnesemia, congenital QT interval prolongation, hepatic impairmentSprycel should Use with caution in patients who have or may develop prolongation of QT interval..
For More Information :
Call Us : +91- 9987711567
Mail to : applepharmaceutical@gmail.com.
Comments
Post a Comment